...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Filing of Quarterly Financial Statements and Management's Discussion & Analysis

I just received clarification back from Clayton regarding the futility analysis:

"The DSMB and the clinical steering committee are in discussions as to the most appropriate timing for the futility analysis, ranging anywhere from 50% to 75% of the events. When a final decision is made it will be announced. The discussions are based solely on statistical analysis factors and not on clinical results."

BearDownAZ

Share
New Message
Please login to post a reply